Date of this Version
Biomedical researchers often assume that sponsors, subjects, families, and disease-associated advocacy groups contribute to research solely because of altruism. This view fails to capture the diverse interests of many participants in the emerging research enterprise. In the past two decades, patient groups have become increasingly active in the promotion and facilitation of genetics research. Simultaneously, a significant shift of academic biomedical science toward commercialization has occurred, spurred by U.S. federal policy changes.
Merz, J. F., Magnus, D., Cho, M. K., & Caplan, A. L. (2002). Protecting Subjects' Interests in Genetics Research. Retrieved from http://repository.upenn.edu/bioethics_papers/10
Date Posted: 12 March 2007